EtDO-P4

EtDO-P4

Catalog Number:
L002270447BIO
Mfr. No.:
BE180400
Price:
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • EtDO-P4 is a glucosylceramide synthase inhibitor which reduces the cellular levels of glucosylceramide (Glc-Cer) and the common biosynthetic precursor of most glycosphingolipids (GSLs). EtDO-P4 binds to the Glc-Cer synthase in a competitive manner and prevents the transfer of the first glucosyl residue, thus preventing further biosynthetic diversification into more elaborate glycosphingolipds. EtDO-P4 is a ceramide-like compound that was initially developed as a potential therapeutic for the treatment of diseases associated with altered glycosphingolipid levels. EtDO-P4 has also been used to indirectly increase sialylation levels in erythropoietin production. EtDO-P4 has been suggested, as part of compositions, for treatment of cardiac hypertrophy (Kwak, 2017).

          Please contact us at for specific academic pricing.

      • Properties
        • CAS Number
          245329-78-6
          Molecular Formula
          C31H52N2O4
          Molecular Weight
          516.8 g/mol
          Note
          There is no hazardous surcharge associated with this product.
          There is no special packaging charge associated with this product.

          * For research use only. Not for human or veterinary use

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    Copyright © Amerigo Scientific. All rights reserved.